Table 2 Treatment administered during the two successive waves.
From: Trends in management and outcomes of COVID patients admitted to a Swiss tertiary care hospital
Treatment | Overall (n = 2′983) | First wave (n = 1′014) | Second wave (n = 1′969) | p value |
|---|---|---|---|---|
Corticosteroids, n (%) | ||||
No | 1′747 (58.6) | 922 (90.9) | 825 (41.9) | < 0.001 |
Yes | 1′236 (41.4) | 92 (9.1) | 1′144 (58.1) | |
Lopinavir/r, n (%) | – | |||
No | 703 (69.3) | 703 (69.3) | – | |
Yes | 311 (30.7) | 311 (30.7) | – | |
Remdesivir, n(%) | − 1014 (100) | – | ||
No | 2887 (96.8) | – | 1873 (95.1) | |
Yes | 96 (3.2) | 96 (4.9) | ||
Hydroxychloroquin, n (%) | 678 (66.9) | – | ||
No | 678 (66.9) | 336 (33.1) | ||
Y es | 336 (33.1) | |||
Any antibiotics, n (%) | ||||
No | 1′177 (39.5) | 251 (24.8) | 926 (47.0) | < 0.001 |
Yes | 1′806 (60.5) | 763 (75.2) | 1′043 (53.0) | |
Anti-Il6, n (%) | ||||
No Yes | 2′975 (99.7) 8 (0.3) | 1′008 (99.4) 6 (0.6) | 1′967 (99.9) 2 (0.1) | 0.022* |
